SCHEMBL18017

SCHEMBL18017

CCN1C2COC[C@@H]1CC(O)C2

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9971231 0.86
SCHEMBL15976450 0.81
SCHEMBL23671801 0.79 LMNA (0.54) LMNACYP2C9
SCHEMBL23133699 0.79 LMNA (0.54) LMNACYP2C9
SCHEMBL23467552 0.79 LMNA (0.54) LMNACYP2C9
SCHEMBL23671794 0.79 LMNA (0.54) LMNACYP2C9
SCHEMBL10362732 0.79 LMNA (0.54) LMNACYP2C9
SCHEMBL8236140 0.77 LMNA (0.41) LMNACYP2C9
SCHEMBL15444767 0.77 ALDH1A1 (0.31)
SCHEMBL12313390 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed